You are here: Industry Insights > Bharat Biotech

News List

SEC recommends phase II/III clinical trials of Covaxin on 2-18 year-olds expresspharma
May 13, 2021
The trial will be conducted on 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.
Bharat Biotech begins direct supply of COVAXIN to 14 states expresspharma
May 11, 2021
The firm has started supplying its COVID-19 vaccine to the states based on the allocations received by the central government.
Tech transfers, collaborations, materials supply key to scale up vaccine manufacturing: Suchitra Ella expresspharma
May 10, 2021
Bharat Biotech is in the process of ramping up the manufacturing capacity of Covaxin to 70 crore dosages per annum.
Covaxin prices slashed from Rs 600 to Rs 400 per dose for states expresspharma
April 30, 2021
The announcement came one day after the Serum Institute of India, reduced the price of Covishield from ₹400 to ₹300.
Efforts to ramp up production of COVID-19 vaccines, easy availability underway: Renu Swarup expresspharma
April 23, 2021
The regulators have also permitted manufacturing at risk and stockpiling doses even before approval so that they can be rolled out into the immunisation programme without any time lag, she said.
Bharat Biotech, ICMR announce interim results from Phase 3 trials of COVAXIN expresspharma
April 22, 2021
Bharat Biotech announced phase 3 interim analysis results of COVAXIN. The second interim analysis is based on accruing more than 87 symptomatic cases of COVID-19. Due to the recent surge in cases, 127 symptomatic cases were recorded, resulting in a ...
India approves $610 million grant for Serum Institute, Bharat Biotech to boost vaccine production capacity expresspharma
April 21, 2021
India’s government has approved a 45.67-billion-rupee ($610 million) grant for COVID-19 vaccine makers Serum Institute of India (SII) and Bharat Biotech to boost production capacity as infections spread at record speed, its finance minister said.
Bharat Biotech announces COVAXIN capacity expansion expresspharma
April 21, 2021
Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for COVAXIN.
Haffkine Bio-Pharma to target 22.8 crore Covaxin vials annually expresspharma
April 19, 2021
After receiving permission to make Bharat Biotech’s COVID-19 vaccine Covaxin, Haffkine Bio-Pharmaceutical said it would take least at one year’s time for the company to start actual production.
PSUs roped in to ramp up COVID-19 vaccine production expresspharma
April 19, 2021
The production of indigenously developed COVID-19 vaccine Covaxin will be ramped up significantly and increased to 10 crore doses per month by September, the Department of Biotechnology said.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page